Learn More
Abcam AS601245 JNK Inhibitor, Selective, ATP Competitive, Solid, 25 mg
Description
- Potent and selective: ATP-competitive JNK inhibitor.
- Activity: IC50 values are 150 nM, 220 nM, and 70 nM for hJNK1, hJNK2, and hJNK3 respectively.
- Biological effects: Reduces cell adhesion and migration in cancer cells; exhibits neuroprotective and anti-ischemic effects in vivo.
- Properties: Blood-brain barrier permeable and cell-permeable.
- Purity: >95%.
- Molecular weight: 372.4 Da.
- Form: Solid.
The product is subject to the following: Abcam Restricted Use Statement
Specifications
Specifications
| Target Molecule | JNK (hJNK1, hJNK2, hJNK3) |
| Shipping Condition | Ambient |
| Form | Solid |
| Alternate Part Number | AS601245 |
| Buffer | 100% 2-(1,3-benzothiazol-2-yl)-2-[2-(2-pyridin-3-ylethylamino)pyrimidin-4-yl]acetonitrile |
| Content And Storage | Store at -20°C. |
| Formulation | 100% 2-(1,3-benzothiazol-2-yl)-2-[2-(2-pyridin-3-ylethylamino)pyrimidin-4-yl]acetonitrile |
| Quantity | 25 mg |
| For Use With (Application) | Cancer research, Neuroprotection, Anti-ischemic studies |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.